Literature DB >> 1692231

Increased CD5+ B cells in infectious mononucleosis.

J Hassan, C Feighery, B Bresnihan, A Whelan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692231     DOI: 10.1111/j.1365-2141.1990.tb02604.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Effect of gold therapy on CD5+ B-cells and TCR gamma delta+ T-cells in patients with rheumatoid arthritis.

Authors:  J Hassan; C Feighery; B Bresnihan; A Whelan
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.

Authors:  E Zuckerman; G Slobodin; A Kessel; E Sabo; D Yeshurun; K Halas; E Toubi
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

3.  Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment.

Authors:  Elias Toubi; Aharon Kessel; Regina Peri; Zehava Shmuel; Ellen Bamberger; Edmond Sabo; Eli Zuckerman
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

4.  Prevalence of anti-Fab antibodies in patients with autoimmune and infectious diseases.

Authors:  J Hassan; C Feighery; B Bresnihan; A Whelan
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

5.  Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis. The Leishmania Study Group.

Authors:  H Louzir; L Belal-Kacemi; A Sassi; D Laouini; R Ben Ismail; K Dellagi
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.